← Back to Insights
December 12, 2019
Authors
Alina-Bonn
Topics
Economics Innovation
Channels
4sight Radio & TV Interviews Podcasts

Podcast: Commercializing Breakthrough Drugs in a Value-Based Market

What does it take to bring a breakthrough drug to a value-based market? John Kerins, Director at Cain Brothers, a division of KeyBanc Capital Markets Inc., and David Johnson discuss the intensified need for data, collaboration and communication to bring exceptionally costly but desperately needed therapies to market. They hone in on the growing role of medical affairs and contract commercialization services organizations in meeting the needs of all stakeholders for value.

John and Dave also co-authored a detailed article on the topic. Read it here.

About the Author

Alina-Bonn

Alina focuses on copywriting, email marketing, social media campaigns and other marketing strategies for 4sight Health. Alina is passionate about helping entrepreneurs and service-based businesses increase revenue with digital and social media marketing solutions. Her professional background blends marketing, event management and business administration.

Before 4sight Health, Alina helped other business consultants and professional speakers grow their businesses online. Prior to that, she was a conference coordinator at an international finance association in Manhattan.

Alina received her Bachelor’s in business administration from The King’s College, a classical liberal arts school near Wall St. She now lives in her hometown of Omaha, NE, where she continues to learn top marketing strategies from industry leaders in digital classrooms. Alina enjoys running races, exploring greenhouses and planning new travels.

Recent Posts

Consumerism
Pay as You Portal
Time is money. Even in healthcare. Which shouldn’t be a surprise because healthcare is no different from other… Read More
By April 9, 2025
Innovation
Revenue Cycle Dystopia: Olives With No Juice
4sight Health’s David W. Johnson says the dramatic collapse of Olive AI reveals the false promises of automation… Read More
By April 8, 2025
Innovation
Podcast: Sequencing the Fallout from the 23andMe Collapse 4/3/25
What are the personalized medicine and market lessons from the fall of 23andMe, the direct-to-consumer genetic testing company?… Read More
By April 3, 2025